Aelin Therapeutics

Developer of antibiotics based on protein aggregation approach

placeLeuven, Flemish Region, Belgium calendar_todayFounded 2017 groups35 employees language aelintx.com

Registered entities

Investor mix

7 investors on record; lead investors include Life Sciences Partners; 1 has since exited.

Investor typeCountShare
Venture capital229%
Private equity229%
Bank & private debt114%
Other / undisclosed229%
Coming soon